MPM Capital

MPM Capital is a prominent venture capital firm specializing in biotechnology investments. With nearly three decades of experience, the firm focuses on translating scientific innovations into cures for major diseases. Their expertise spans scientific research, clinical development, and company-building, aiming to power novel medical breakthroughs that transform patients' lives.

The firm's investment strategy encompasses early-stage venture capital funds, as well as impact and public equities products through its affiliate, BioImpact Capital. MPM Capital's portfolio includes a diverse range of companies across the biotech landscape, with a particular emphasis on therapeutics and enabling technologies.

Headquartered in Cambridge, Massachusetts, MPM Capital operates additional offices in San Francisco, California, and Munich, Germany. The firm manages assets totaling approximately $3.3 billion across 21 funds, employing a team of 50 professionals dedicated to advancing healthcare through strategic investments.